Parallel Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162K | Buy |
4,488
+65
| +1% | +$2.34K | ﹤0.01% | 1105 |
|
|
2025
Q1 | $138K | Buy |
4,423
+798
| +22% | +$24.8K | ﹤0.01% | 1127 |
|
|
2024
Q4 | $92.5K | Buy |
3,625
+1,144
| +46% | +$29.2K | ﹤0.01% | 1307 |
|
|
2024
Q3 | $70.2K | Buy |
2,481
+757
| +44% | +$21.4K | ﹤0.01% | 1430 |
|
|
2024
Q2 | $45.5K | Sell |
1,724
-1,331
| -44% | -$35.1K | ﹤0.01% | 1570 |
|
|
2024
Q1 | $92.8K | Buy |
3,055
+173
| +6% | +$5.25K | ﹤0.01% | 1204 |
|
|
2023
Q4 | $81K | Buy |
2,882
+1,111
| +63% | +$31.2K | ﹤0.01% | 1204 |
|
|
2023
Q3 | $48.1K | Buy |
1,771
+652
| +58% | +$17.7K | ﹤0.01% | 1414 |
|
|
2023
Q2 | $34.4K | Buy |
1,119
+215
| +24% | +$6.61K | ﹤0.01% | 1588 |
|
|
2023
Q1 | $32.6K | Buy |
904
+741
| +455% | +$26.7K | ﹤0.01% | 1597 |
|
|
2022
Q4 | $6.44K | Sell |
163
-214
| -57% | -$8.46K | ﹤0.01% | 2216 |
|
|
2022
Q3 | $15K | Buy |
377
+203
| +117% | +$8.08K | ﹤0.01% | 1797 |
|
|
2022
Q2 | $7K | Sell |
174
-120
| -41% | -$4.83K | ﹤0.01% | 2128 |
|
|
2022
Q1 | $11K | Buy |
294
+34
| +13% | +$1.27K | ﹤0.01% | 1969 |
|
|
2021
Q4 | $10K | Buy |
260
+225
| +643% | +$8.65K | ﹤0.01% | 2111 |
|
|
2021
Q3 | $1K | Buy |
+35
| New | +$1K | ﹤0.01% | 2922 |
|